# Multi-Omics Clinical Diagnostic Report

---

- **Patient ID**: BORDERLINE_TEST_001
- **Report Date**: 2026-01-06T20:22:21.205358
- **Report ID**: 4863678064

---

## Executive Summary

### Final Diagnosis

**Periodontitis**

**Confidence Level**: Moderate ⚠️ (80.7%)

### Key Findings

- **Expert Consensus**: 3 expert opinions analyzed
- **Conflict Resolution**: fallback_voting
- **Key Biomarkers**: Porphyromonas_gingivalis, Butyrate, Propionate

## Multi-Omics Analysis

### Microbiome Analysis

- **Predicted Diagnosis**: Periodontitis
- **Confidence**: 92.0%
- **Probability**: 88.0%

**Top Biomarkers**:

- Porphyromonas_gingivalis: upregulated (importance: 0.400)
- Treponema_denticola: upregulated (importance: 0.320)
- Prevotella_intermedia: upregulated (importance: 0.150)

### Metabolome Analysis

- **Predicted Diagnosis**: Periodontitis
- **Confidence**: 90.0%
- **Probability**: 86.0%

**Top Biomarkers**:

- Butyrate: upregulated (importance: 0.380)
- Propionate: upregulated (importance: 0.350)
- Acetate: upregulated (importance: 0.120)

### Proteome Analysis

- **Predicted Diagnosis**: Healthy
- **Confidence**: 60.0%
- **Probability**: 55.0%

**Top Biomarkers**:

- IgA: upregulated (importance: 0.300)
- MMP9: upregulated (importance: 0.280)
- IL6: upregulated (importance: 0.250)


## Diagnostic Rationale

2/3个专家支持Periodontitis诊断。 平均置信度: 80.7% 通过fallback_voting解决了专家意见分歧。

## Key Biomarkers

| Biomarker | Omics Type | Direction | Importance | Description |
|-----------|------------|-----------|------------|-------------|
| Porphyromonas_gingivalis | microbiome | up | 0.000 | N/A |
| Butyrate | metabolome | up | 0.000 | N/A |
| Propionate | metabolome | up | 0.000 | N/A |
| Treponema_denticola | microbiome | up | 0.000 | N/A |
| IgA | proteome | up | 0.000 | N/A |
| MMP9 | proteome | up | 0.000 | N/A |
| IL6 | proteome | up | 0.000 | N/A |
| Prevotella_intermedia | microbiome | up | 0.000 | N/A |
| Acetate | metabolome | up | 0.000 | N/A |

## Expert Opinions

### Expert 1: microbiome_expert

**Omics Type**: microbiome

**Diagnosis**: Periodontitis
**Probability**: 88.0%
**Confidence**: 92.0%

**Biological Explanation**:

HIGH levels of P.gingivalis (22x) and T.denticola (20x) detected

**Evidence Chain**:

- Strong pathogenic signal
- Consistent with periodontal disease

### Expert 2: metabolome_expert

**Omics Type**: metabolome

**Diagnosis**: Periodontitis
**Probability**: 86.0%
**Confidence**: 90.0%

**Biological Explanation**:

HIGH butyrate (28x) and propionate (25x) levels

**Evidence Chain**:

- Elevated inflammatory metabolites
- Supports periodontal diagnosis

### Expert 3: proteome_expert

**Omics Type**: proteome

**Diagnosis**: Healthy
**Probability**: 55.0%
**Confidence**: 60.0%

**Biological Explanation**:

IgA levels slightly elevated but MMP9 also present (mixed signals)

**Evidence Chain**:

- Mixed signals detected
- Borderline classification


## Conflict Resolution

**Conflict Types**: diagnosis_disagreement
**Resolution Method**: fallback_voting
**Debate Rounds**: 0
**RAG Used**: Yes
**CAG Used**: Yes


## Clinical Recommendations

1. Diagnosis: Periodontitis (consensus-based)
2. LLM reasoning not available
3. Manual review recommended

## References and Evidence

### Supporting Medical Literature

1. **Periodontal Disease and Oral Microbiome** - PubMed:12345678 ([link](https://pubmed.ncbi.nlm.nih.gov/12345678))
2. **Diagnosis and Treatment of Periodontitis** - Clinical Guidelines 2023
3. **Butyrate Production and Periodontal Health** - J Clin Microbiol 2024

### Similar Historical Cases

1. Case CASE_2023_001: Periodontitis (similarity: 89.0%)
2. Case CASE_2023_045: Periodontitis (similarity: 85.0%)

## Limitations and Follow-up

### Limitations

- **Expert Disagreement**: Experts had conflicting opinions
  which were resolved through debate and evidence review
- **Multi-omics Integration**: Results are based on computational
  integration of multi-omics data and should be validated clinically

### Recommended Follow-up

1. Clinical validation by specialist
2. Additional diagnostic tests if confidence < 80%
3. Longitudinal monitoring of key biomarkers
4. Re-evaluation if symptoms change

## Technical Metadata

- **Decision Type**: conflict_resolution
- **Conflict Detected**: True
- **Number of Experts**: 3

---

*This report was generated by the Multi-Omics Clinical Diagnosis System.*

*For questions or concerns, please consult with a qualified healthcare professional.*